Product Liability

Tesla Cybertruck Recall & Products Liability Class Action

Tesla Cybertruck Recall & Products Liability Class Action — Product Liability class action lawsuit

Case Overview

Shortly after Tesla began delivering the long-awaited Cybertruck in late 2023, reports emerged of a critical safety defect: the accelerator pedal pad could detach or become dislodged and lodge against the interior trim, causing the vehicle to accelerate to full throttle without driver input. Tesla issued a recall in April 2024 covering approximately 3,878 Cybertrucks — representing nearly the entire fleet delivered at that time — after the National Highway Traffic Safety Administration (NHTSA) opened an investigation. At least one crash was linked to the defect before the recall was announced. The recall was one of several issued for the Cybertruck in its first year, raising broader questions about the vehicle's readiness for consumer sale.

The class action lawsuit alleges that Tesla was aware of the accelerator pedal defect before vehicles were delivered to customers but concealed the information, forcing buyers to unknowingly operate dangerous vehicles. Plaintiffs assert claims for negligence, strict products liability, breach of express and implied warranty, violation of the California Consumers Legal Remedies Act (CLRA), and fraudulent concealment. The suit seeks compensation for diminished vehicle value, out-of-pocket repair costs, and damages for the safety risks to which owners were exposed. The litigation is part of a broader pattern of scrutiny of Tesla's quality control practices across its vehicle lineup.

Who May Qualify

You may be eligible if you purchased or leased a Tesla Cybertruck, particularly a 2024 model year vehicle, and experienced the accelerator pedal defect, received a recall notice, or suffered diminished value or other damages as a result of the defects.

Frequently Asked Questions

Is my Tesla Cybertruck covered by the accelerator pedal recall?

The April 2024 recall covered approximately 3,878 Cybertrucks from the 2024 model year. Tesla pushed a software update and offered a hardware fix. If you own a Cybertruck, check NHTSA's recall database at nhtsa.gov with your VIN.

Can I join the Cybertruck class action even if my pedal didn't stick?

Potentially yes. Class members may include all Cybertruck purchasers who suffered diminished vehicle value due to the defect, even if they did not personally experience a pedal-entrapment incident.

How many Cybertrucks were affected by the recall?

The initial recall covered nearly 3,878 vehicles, representing essentially all Cybertrucks delivered as of the recall date. Multiple subsequent recalls for separate defects have also been issued for the Cybertruck.

Related Cases

Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) Mass Tort Litigation — Product Liability class action lawsuit

Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) Mass Tort Litigation

Current
Product Liability
Women who received long-term Depo-Provera (injectable contraceptive) injections are suing Pfizer, alleging the drug significantly increases the risk of developing meningioma brain tumors and that the company failed to warn patients and physicians of this risk despite knowing about it for years.
Social Media Addiction & Youth Mental Health School District MDL — Product Liability class action lawsuit

Social Media Addiction & Youth Mental Health School District MDL

Current
Product Liability
Hundreds of school districts and personal injury plaintiffs allege that Meta, Snap, TikTok, and YouTube deliberately designed their platforms to be addictive to children and teenagers, causing a nationwide youth mental health crisis resulting in anxiety, depression, self-harm, eating disorders, and suicide.
Ozempic / Mounjaro GI Injury (Gastroparesis & Bowel Obstruction) Products Liability MDL — Product Liability class action lawsuit

Ozempic / Mounjaro GI Injury (Gastroparesis & Bowel Obstruction) Products Liability MDL

Current
Product Liability
Patients who used GLP-1 receptor agonist drugs Ozempic (semaglutide) and Mounjaro (tirzepatide) for weight loss or diabetes management allege they suffered severe gastrointestinal injuries — including gastroparesis (stomach paralysis), bowel obstruction, and intestinal ileus — that were not adequately disclosed in the drugs' warnings.